Julia Iris is an accomplished professional with extensive experience in marketing and strategic leadership within the healthcare sector. Currently serving as the US HCP Lead for Hemophilia Gene Therapy and Director of Sickle Cell Disease at Pfizer since December 2022, Julia has previously held significant roles, including Brand Lead at Almirall and Associate Director of Oncology Marketing at Teva Pharmaceuticals, where successful launch strategies were developed for oncology biosimilars. Julia's early career includes positions at Wyeth Consumer Healthcare, McNeil Consumer, and CSL Behring, focusing on the development and execution of marketing strategies for various pharmaceutical products. Julia holds a Bachelor of Science in Chemical Engineering from the University of Pennsylvania and an MBA in Marketing and Strategy from Northwestern University's Kellogg School of Management.
This person is not in the org chart
This person is not in any teams
This person is not in any offices